Back to Journals » Cancer Management and Research » Volume 11

Original Research

Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib

       
Total article views   HTML views PDF downloads Totals
6,792 Dovepress* 6,243+ 720 6,963
PubMed Central* 549 127 676
Totals 6,792 847 7,639
*Since 5 September 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed and Google Scholar